LifeVantage granted third patent for Protandim

San Diego-based LifeVantage Corp. (OTC: LFVN), has been granted a third patent for its flagship product Protandim. Protandim has been clinically proven in earlier studies to slow the progressive rate of aging by reducing oxidative stress.

Click below for the complete press release.

 

More LifeVantage News and Articles

 

LifeVantage Profile

Create a Free LifeVantage Rep Listing